Tumor targeting using liposomal antineoplastic drugs
Jörg Huwyler1, Jürgen Drewe2, Stephan Krähenbühl21University of Applied Sciences Northwestern Switzerland, Institute of Pharma Technology, Muttenz, Switzerland; 2Department of Research and Division of Clinical Pharmacology, University Hospital Base...
Guardado en:
Autores principales: | Jörg Huwyler, Jürgen Drewe, Stephan Krähenbühl |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/329bc4eda00f43dfb5b77bec7ef53dcd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
por: Scherzinger-Laude K, et al.
Publicado: (2013) -
Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties
por: Gradauer K, et al.
Publicado: (2012) -
Bilateral horizontal Vogt’s striae in keratoconus
por: Inci Ulu Güngör, et al.
Publicado: (2008) -
Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells
por: Torsten Hans Schroeder, et al.
Publicado: (2008) -
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
por: Andreas Rogalewski, et al.
Publicado: (2007)